|
Oct 17
|
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV
|
|
Oct 17
|
Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
|
|
Oct 17
|
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
|
|
Oct 11
|
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Oct 11
|
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ...
|
|
Oct 10
|
Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit
|
|
Oct 10
|
Theratechnologies: Fiscal Q3 Earnings Snapshot
|
|
Oct 10
|
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024
|
|
Sep 26
|
Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update
|
|
Sep 9
|
Theratechnologies to Present at Upcoming Investor Conferences in September
|
|
Aug 26
|
Positive Signs As Multiple Insiders Buy Theratechnologies Stock
|
|
Jul 16
|
Theratechnologies Second Quarter 2024 Earnings: Beats Expectations
|
|
Jul 16
|
Despite Fast-paced Momentum, Theratechnologies (THTX) Is Still a Bargain Stock
|
|
Jun 26
|
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
|
|
May 9
|
Theratechnologies Reports on its Annual Meeting of Shareholders
|
|
May 2
|
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
|
|
Apr 23
|
Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Apr 15
|
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
|
|
Apr 11
|
Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
|
Apr 10
|
Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
|